{'52WeekChange': 0.42240107,
 'SandP52WeekChange': 0.0644362,
 'address1': 'Building 1',
 'address2': 'Suite 100 41 Seyon Street',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 143.5,
 'askSize': 900,
 'averageDailyVolume10Day': 401012,
 'averageVolume': 666303,
 'averageVolume10days': 401012,
 'beta': 1.053781,
 'beta3Year': None,
 'bid': 130.01,
 'bidSize': 1100,
 'bookValue': 20.463,
 'category': None,
 'circulatingSupply': None,
 'city': 'Waltham',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 135.22,
 'dayLow': 132.03,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': 0.219,
 'enterpriseToEbitda': 103.518,
 'enterpriseToRevenue': 23.677,
 'enterpriseValue': 6764517888,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '781 250 0115',
 'fiftyDayAverage': 123.15143,
 'fiftyTwoWeekHigh': 143.93,
 'fiftyTwoWeekLow': 72.32,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 48476440,
 'forwardEps': 1.32,
 'forwardPE': 101.78787,
 'fromCurrency': None,
 'fullTimeEmployees': 761,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.07428,
 'heldPercentInstitutions': 0.85103,
 'industry': 'Medical Instruments & Supplies',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/repligen.com',
 'longBusinessSummary': 'Repligen Corporation develops and commercializes '
                        'bioprocessing technologies and systems that are used '
                        'in biological drug manufacturing process in North '
                        'America, Europe, the Asia Pacific, and '
                        'internationally. It offers Protein A ligands that are '
                        'the binding components of Protein A affinity '
                        'chromatography resins; and cell culture growth factor '
                        "products. The company's chromatography products "
                        'include OPUS pre-packed chromatography columns, which '
                        'are used in the purification of biologics; and OPUS '
                        'smaller-scale columns that are used in the high '
                        'throughput process development screening, viral '
                        'clearance validation studies, and scale down '
                        'validation of chromatography processes. It also '
                        'offers ELISA kits, which are analytical test kits to '
                        'quantitate the proteins and growth factors; '
                        'chromatography resins under the CaptivA brand; and '
                        'liquid chromatography products under the '
                        'Spectra/Chrom brand. In addition, the company offers '
                        'filtration products, such as XCell Alternating '
                        'Tangential Flow systems that are filtration devices '
                        'used in upstream perfusion cell culture processing; '
                        'TangenX flat sheet cassettes, which are used in '
                        'downstream biologic drug concentration and '
                        'formulation processes; KrosFlo tangential flow '
                        'filtration and tangential flow depth filtration '
                        'systems; Spectra/Por laboratory and process dialysis '
                        'products, and SpectraFlo dynamic dialysis systems; '
                        'and ProConnex single-use hollow fiber '
                        'module-bag-tubing sets. Further, it provides process '
                        'analytics products, such as slope spectroscopy '
                        'systems under the SoloVPE and FlowVPE brands. The '
                        'company sells its products to life sciences, '
                        'biopharmaceutical, and diagnostics companies; '
                        'laboratory researchers; and contract manufacturing '
                        'organizations. It has a collaboration agreement with '
                        'Navigo Proteins GmbH to develop multiple affinity '
                        'ligands; and Sartorius Stedim Biotech to create novel '
                        'perfusion-enabled bioreactors. Repligen Corporation '
                        'was founded in 1981 and is headquartered in Waltham, '
                        'Massachusetts.',
 'longName': 'Repligen Corporation',
 'market': 'us_market',
 'marketCap': 7027793920,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_33769',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': 23173000,
 'nextFiscalYearEnd': 1640908800,
 'open': 134.53,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': 4.94,
 'phone': '781 250 0111',
 'previousClose': 136.73,
 'priceHint': 2,
 'priceToBook': 6.5659976,
 'priceToSalesTrailing12Months': 24.598423,
 'profitMargins': 0.08111,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 135.22,
 'regularMarketDayLow': 132.03,
 'regularMarketOpen': 134.53,
 'regularMarketPreviousClose': 136.73,
 'regularMarketPrice': 134.53,
 'regularMarketVolume': 375695,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 52305700,
 'sharesPercentSharesOut': 0.0301,
 'sharesShort': 1574162,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 1950432,
 'shortName': 'Repligen Corporation',
 'shortPercentOfFloat': 0.034,
 'shortRatio': 1.64,
 'startDate': None,
 'state': 'MA',
 'strikePrice': None,
 'symbol': 'RGEN',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': 0.458,
 'trailingPE': 293.36246,
 'twoHundredDayAverage': 110.22281,
 'volume': 375695,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.repligen.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '02453'}